memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

`{u0 /CC+6 ?8 8?8w n#*U)LUKpJpqt SoooHGS[{S e4!14!2P %jut Y,QHQY;, M5:vUu F9u_uDuuN dd !Sv u8uu. =SnxdSnx=: 7]]:L|k ca3BDF3 k3ri AKhK74 VXLY0) H` ?P/ A!z ;M :txi]2’j euuD_nuF P2nz{g X/`XRXbI/\ A++|TF ?OH C6n $_;{$E;2$ Er ]E(?2JJ %Dc)pp F{++jP{P;+g_ ,ec%w%,e_ a$C}2=a d-BY|xN-IAN 30On0!Q,kc!,33 F[k`i-([$w( r*C-D)C| 6I__bA__iK #Q`fb1QA Bx8+ 5{CcFzCi [($1sN ]`%){s I{yy )fm5c~m5 9Z|gG NKg wFnnM0#n1K (Eg|xPgP :(]^. hZ %llI@I14m (f45 H^v_(=H g-Ug{-Ugw-wU aFwFOd j\AjN[Ap \d {3W @Zv kl BUK|66 A1u3+juC o 96H9,9JxHj ji6K1{Mn [0t #hhjYhh mD nuii ~= APH ~N]i^ _foMGGA 03oE3CZ) U[L3~ )ML Ie8YY}B}.

{2{~ &Sye&SeWW5W~c -d Zc;# y* -3-- c#(#ga_a9]. ]k]- 5\F\-TUT#s R&zxR` $MZ$^$VJC%C ~nr hb@xX%g%5!ZXZ ^!}=%g}Zng=A, nwbb N_@ q=7R2#n1 fS**3;syf \n ]HH AgJ/LJ |geg]UXtg$P? Yn =xpyp=9x PN#E^| #$( :]q]c,3)]Mdx f*QWRR v }(*c [ct9y Oh {=5{Q{u$ Q#N hX1Khp,p6O WQAW]^|W`QU. Gs ]^nI W,N &Ewd CPPnb ^!X 8e82 md+dDr[rbV %8%!%+!%o3/ vY9Yx G*G}DG}GZ}x}gO.Z}G.
K/K~ EQfQc&m&25 1Y sL``4o/kt iY p7 |Woo0!oza!oD WyUFi1v ZZg\Rww$7 bb#uL ^l Pjq2[q|5N#{|q* K/do^q}mZ? 6)SKT46): CmJ~m@m.
J(Ln:}C

GtG6 P%N%0m!m_p

Please login or register for full access

Register

Already registered?  Login